Davis Polk advised J.P. Morgan Securities LLC as sole book-running manager and representative of the underwriters of a $149 million SEC-registered offering of 1,725,000 shares of common stock of HeartWare International, Inc., including 225,000 shares from the exercise of the underwriters’ over-allotment option. Canaccord Genuity Inc., Credit Suisse Securities (USA) LLC and Lazard Capital Markets LLC acted as co-managers of the offering. The common stock is listed on the Nasdaq Global Market under the symbol “HTWR.”
HeartWare International is a medical device company focused on the development and sale of implantable blood pumps for the treatment of advanced heart failure.
The Davis Polk corporate team included partner Deanna L. Kirkpatrick, associates Nicholas J. Dashman and Jeffrey Hamilton and law clerk Jon B. Shields. Partner Samuel Dimon and associate Nicole P. Field provided tax advice. Associate Bruce Rose-Innes provided intellectual property advice. Members of the Davis Polk team are based in the New York and Menlo Park offices.
Related Posts:
- Davis Polk – ChemoCentryx, Inc. Common Stock Offering
- Davis Polk – Cardiovascular Systems, Inc. Common Stock Offering
- Davis Polk – Splunk Initial Public Offering
- Davis Polk – Rally Software Initial Public Offering
- Davis Polk – Isis Pharmaceuticals, Inc. Common Stock Offering
